Amanote Research
Register
Sign In
Combo Drug Strategy Tested for PDAC
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2019-037
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
March 19, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Drug Combo May Be Effective in Ovarian Cancer
Cancer Discovery
Oncology
Combo Index
Targeted Combo Effective for Refractory Ewing Sarcoma
Cancer Discovery
Oncology
Combo Therapy for Lung Cancer Extends Survival
Cancer Discovery
Oncology
Combo That, Please!
Science
Multidisciplinary
Philosophy of Science
History
Validating the Vitality Strategy for Fighting Drug Resistance
Proteins: Structure, Function and Genetics
Biochemistry
Structural Biology
Molecular Biology
Atezolizumab Combo Approved for PD-L1–positive TNBC
Cancer Discovery
Oncology
Epigenomic Changes Prime PDAC Metastasis
Cancer Discovery
Oncology
A New B-Raf Inhibitor Combo for Advanced Melanoma
Oncotarget
Oncology